Our mission at the Multiple Sclerosis Clinic of New Orleans at the Louisiana State University is to provide the best possible care to patients with multiple sclerosis, to conduct research that will lead to new and better treatments for this disease, and to educate new neurologists in how to deliver state-of-the art care for people with MS. We are also committed to MS community outreach with regard to educational programs for both MS patients and MS care providers. 

We strive to become the leading MS center for southern Louissiana, Mississippi and Alabama. 

There is great hope for patients diagnosed with multiple sclerosis. Currently, there are four FDA-approved first-line MS therapies (Interferon beta-1a (Avonex, Rebif), interferon beta-1b (Betaseron) and glatiramer acetate (Copaxone) that are both safe and are effective for multiple sclerosis.  More agressive treatment options (Natalizumab (Tysabri) and mitoxantrone (Novantrone) for those patients who need them.  There are also multiple new MS therapies that will be available in the near future including both oral agents and new infusions. We are confortable with managing all these therapies.

Our goal at the MS Clinic of New Orleans at LSU is to provide our patients with an individualized treatment plan that considers the whole patient. 

In our clinic, we have three fellowship-trained, board-certified neurologists who are devoted to the care of patients with MS, as well as two nurses who have extensive experience caring for MS patients.  We have developed a multi-disciplinary model of care at LSU so that our MS patients have direct and easy access to experts at LSU the fields of urology, rehabilitation, psychiatry, neurosurgery, and others.  We also actively partner with several providers in the community in the fields of radiology, physical and occupational therapy, neuropsychology, and others. 

Our patients come mainly from the New Orleans area but also from Baton Rouge,LA, Lafayette,LA, Gulfport, MS, Biloxi, MS, Mobile, AL. We have built a network of other providers in these areas to provide additional specialty care that patients with MS need. 

As MS physicians, we also seek to contribute to the development of new treatments by participating in multicenter trials of new medications as well as conducting our own research efforts.  Patients in our clinic regularly have opportunities to participate in clinical trials of new medications.